Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for...
PranaX Corporation, a leading biotechnology company focused on regenerative biologics, today announced the closing of its oversubscribed $17 million Series A financing. The Series...
PranaX Corporation, a Houston, TX-based biotechnology company focused on regenerative biologics, has raised $17 million in Series A funding.
The Series A round was led...
Tenpoint Therapeutics, Ltd., a global,commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate visionin the aging eye, today announced it has secured $235...
Think Bioscience ("Think Bio"), a biotechnology company focused on unlocking elusive drug targets, has raised $55M in an oversubscribed Series A. The round was...
Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the completion of a Series F...
MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative diseases, today announced that its parent company, MEDIPOST...
Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, today announced the closing of an oversubscribed...
